medicare coverage for semaglutide 💉 is making popular weight-loss medications more affordable some patients. Starting July 1, 2026, eligible Medicare beneficiaries may be able to access certain GLP-1 weight-loss drugs for just $50 per Medicare's new $50 weight-loss drug

Ashley began working for

Though doctors prescribe GLP-1 RAs for many reasons, the two most common are weight management and type 2 diabetes management

Key highlights Tirzepatide is the active ingredient in Mounjaro and Zepbound, while semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus

She explains that flexible tapering strategies are key to successful antidepressant discontinuation in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care Dietitian Sarah MacAvoy explains that while new weight-loss medications show exciting potential, they also put patients at risk of nutritional deficiencies, and dietitian support is essential Kia ora and welcome to Pharmacy Today Kaitiaki Rongo O Te W Not a subscriber